EP Patent

EP2765993B1 — Formulations of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2, 3-dihydro-1h-isoindol-4-yl}-amide

Assigned to Amgen Europe GmbH · Expires 2020-05-20 · 6y expired

What this patent protects

Patent listed against chembl-chembl43452.

Drugs covered by this patent

Patent Metadata

Patent number
EP2765993B1
Jurisdiction
EP
Classification
—
Expires
2020-05-20
Drug substance claim
No
Drug product claim
No
Assignee
Amgen Europe GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.